Wockhardt Stock (NSE:WOCKPHARMA)


INR 214.00
Today's Range
INR213.00 - INR215.65
52-Week Range
INR210.05 - INR592.00
Market Cap

About Wockhardt (NSE:WOCKPHARMA)

(NSE:WOCKPHARMA) Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 and WCK 2349 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 5222, WCK 4282, WCK 4873, and WCK 6777 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.
Show more


Statistics Highlights (NSE:WOCKPHARMA)

Shares Outstanding 144.06M Beta 1.50
Public Float 53.90M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 69.48% Ex-Dividend Date Nov 17, 2016
Held by Institutions 1.96% IPO Date -

WOCKPHARMA Financial Summary

Mar 22 Mar 21 Mar 20
Revenue INR32.30B INR26.99B INR28.33B
Net Income INR-2.44B INR6.86B INR-692.20M
Total Assets INR82.43B INR77.73B INR81.79B
Total Cash INR4.06B INR2.32B INR2.19B
Total Debt INR INR26.73B INR35.82B
Mar 22 Dec 21 Sep 21
Revenue INR6.55B INR8.54B INR8.62B
EBITDA INR-2.02B INR1.14B INR973.90M
Net Income INR-2.58B INR-67.80M INR335.30M
Total Assets INR82.43B INR INR80.09B
Total Cash INR4.06B INR INR2.50B
Total Debt INR INR INR27.60B

WOCKPHARMA Stock Price History

Wockhardt Annual Stock Price History

Year Open Close Change
2021 INR401.60 INR214.00 -46.71%
2021 INR544.50 INR401.60 -26.24%
2020 INR240.00 INR544.50 126.87%

Wockhardt Daily Stock Price History

Date Open High Low Close Change Volume
Jun 23, 2022 INR216.80 INR224.00 INR216.15 INR221.50 -8.70% 271.17K
Jun 10, 2022 INR243.30 INR247.95 INR241.85 INR242.60 -5.35% 347.63K
Jun 7, 2022 INR262.00 INR262.00 INR252.95 INR256.30 11.90% 383.00K


What is today's stock price of Wockhardt (NSE:WOCKPHARMA)?

  • The current stock price of Wockhardt (NSE:WOCKPHARMA) is INR214.00.
  • Today WOCKPHARMA stock price opened at INR214.00 after previous close of INR212.65.
  • During the day, Wockhardt stock quote has varied from a low of INR213.00 to a high of INR215.65.

What is Wockhardt's 52-week change?

  • WOCKPHARMA 52-week high stock quote is INR592.00, which is 176.60% above the current share price.
  • The Wockhardt (NSE:WOCKPHARMA) 52-week low stock price is INR210.05, which is 1.80% below the current share price.
  • Wockhardt share price volatility (52-week beta) is 1.50.


How Much is Wockhardt Worth?

Wockhardt's worth today based on market capitalisation is INR30.83B

How much dividend does Wockhardt Pay?

The current annualized dividend payout for WOCKPHARMA stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Wockhardt's "Dividend" Section

What is Wockhardt’s Price to Earning (PE) ratio?

WOCKPHARMA stock also has a Price to Sales (P/S) ratio of 0.95.

What is the Wockhardt's ticker?

Wockhardt trades on the NSE stock market in India under the ticker symbol "WOCKPHARMA". Wockhardt’s stock symbol can also be displayed as "NSE:WOCKPHARMA".

Who are the owners of Wockhardt?

Wockhardt (NSE:WOCKPHARMA) is owned by 1.96% institutional shareholders and by 69.48% insiders. The rest is owned by the public.
Explore More Details on Wockhardt's “Ownership” Section

Who are the key executives of Wockhardt (WOCKPHARMA)?

Wockhardt's key executive team includes the following managers:

  • Dr. Habil Fakhruddin Khorakiwala, Founder & Exec. Chairman (1941)
  • Dr. Murtaza Habil Khorakiwala, MD & Exec. Director (1973)
  • Dr. Huzaifa Habil Khorakiwala, Exec. Director (1971)
  • Ms. Pradnya Deshmukh, Pres and Global Head of Quality & Compliance (NA)
  • Mr. Deepak Madnani, Chief Financial Officer (NA)
  • Mr. Prem Singh, Pres of Global HR (NA)
  • Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA, Sr. VP of Bus. Devel. (1951)
  • Mr. Georg Cubuk, Managing Director of Esparma - Germany (NA)
  • Mr. Sunil Kumar, Pres of Americas, Emerging Market & Japan (1954)
  • Mr. Zoher T. Sihorwala, Head of Global Regulatory Affairs (1970)

What is Wockhardt’s Sector & Industry Classification?

Wockhardt (NSE:WOCKPHARMA) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Wockhardt?

Currently the number of employees working for Wockhardt is 5,000.

Where are Wockhardt's Headquarters?

Wockhardt (NSE:WOCKPHARMA) is headquartered in India.

What are Wockhardt's Address and Phone Number?

Wockhardt’s mailing address is Wockhardt Towers, Mumbai, India, 400051.
The company’s phone number is 91 22 2653 4444.

What is the official website for Wockhardt?

Wockhardt’s official website is http://www.wockhardt.com